Freedom Bioscience
Freedom Biosciences is a Yale spin-out and clinical stage biotech company developing next generation depression treatments based on ketamine and 5th-based tryptamines.
Freedom Biosciences is a Yale spin-out and clinical stage biotech company developing next generation depression treatments based on ketamine and 5th-based tryptamines.